Analystreport

Turning Point Therapeutics, Inc. (NASDAQ: TPTX) was given a new $76.00 price target on by analysts at Guggenheim.

Turning Point Therapeutics, Inc. - Common stock  (TPTX) 
Last turning point therapeutics, inc. - common stock earnings: 3/16 09:00 am Check Earnings Report